Changeflow GovPing Pharma & Drug Safety Patent Application for Dichrostachys glomerata ...
Routine Notice Added Draft

Patent Application for Dichrostachys glomerata Health Benefits

Email

Summary

The USPTO has published a patent application (US20260083794A1) detailing methods and compositions using Dichrostachys glomerata for various health benefits, including reducing anxiety and improving mood. The application was filed on September 26, 2024, and is expected to be published on March 26, 2026.

What changed

This document is a USPTO patent application (US20260083794A1) for methods and compositions utilizing Dichrostachys glomerata to achieve health and wellness benefits in mammals. Specifically, the application claims efficacy in reducing anxiety, food cravings, and stress, while improving mood, physical and mental health, energy, and happiness. The described compositions are intended for oral administration in forms such as pills, capsules, liquids, lozenges, or tablets.

As this is a patent application, it does not impose immediate regulatory obligations. However, it signals potential future developments in therapeutic products derived from Dichrostachys glomerata. Companies involved in the development or manufacturing of natural health products, pharmaceuticals, or dietary supplements should monitor the progress of this patent application and related intellectual property developments in this area.

Source document (simplified)

← USPTO Patent Applications

METHODS AND COMPOSITIONS USING DICHROSTACHYS GLOMERATA TO REDUCE ANXIETY, FOOD CRAVINGS AND STRESS AND IMPROVE MOOD, PHYSICAL HEALTH, MENTAL HEALTH, ENERGY AND HAPPINESS IN A MAMMAL

Application US20260083794A1 Kind: A1 Mar 26, 2026

Inventors

Shil Kothari

Abstract

Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, stress and improve mood, physical health, mental health, energy and happiness and improve other quality of life factors in one or more mammals, are provided. In one embodiment, a composition for improving mood in a mammal is provided, wherein the composition comprises an effective amount of Dichrostachys glomerata fruit pods provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.

CPC Classifications

A61K 36/48 A61K 9/0053 A61P 25/22 A61P 25/24

Filing Date

2024-09-26

Application No.

18896891

View original document →

Named provisions

Inventors Abstract CPC Classifications Filing Date Application No.

Classification

Agency
USPTO
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083794A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug Development Product Formulation
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Compliance frameworks
FDA 21 CFR Part 11 GxP
Topics
Public Health Consumer Protection

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Therapeutics (A61P) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.